Cathflo Activase Lyophilisate For Solution For Injection 2.2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Cathflo Activase: Lyophilisate for solution for injection (2.2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ALTEPLASE (AL te plase) can dissolve blood clots that form in the heart, blood vessels, or lungs after a heart attack. This medicine is also given to improve recovery and decrease the chance of disability in patients having symptoms of a stroke.

In-Depth Information

Cathflo Activase 2mg Powder for Injection

NDC: 502420041
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ischemic Stroke, Occluded IV Catheter, Pulmonary Embolism

Sometimes used for but not FDA approved for the following conditions:
Acute Myocardial Infarction, Intravascular Catheter Occlusion Prophylaxis, Percutaneous Coronary Intervention (PCI), Deep Venous Thrombosis (DVT), Coronary Artery Thrombosis, Arterial Thromboembolism

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Cathflo Activase 2mg Powder for Injection

Reported Side Effects for Cathflo Activase 2mg Powder for Injection

Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bleeding In The Abdomen Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bleeding In The Brain Incidence:
0.4-15.4%*
Severity: SEVERE
Onset: DELAYED
Bruise Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Brain Attack Incidence:
1.2-1.6%*
Severity: SEVERE
Onset: EARLY
Intestinal Bleeding Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Cathflo Activase

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5